Skip to main content

Arcadia Biosciences, Inc.

corporate_fare Company Profile

Arcadia Biosciences, Inc.

RKDA·NASDAQ·Energy & Transportation·CIK 0001469443

Arcadia develops high-value products and drives innovation in the consumer goods industry. Since acquiring the assets of Zola in May 2021, Arcadia has provided consumers with Zola coconut water products for rehydration, resetting, and reenergizing. Previously, Arcadia developed products, primarily in wheat, which it commercialized through the sale of food products, trait licensing, and royalty agreements. On May 14, 2024, Arcadia sold its non-GMO Resistant Starch ("RS") durum wheat trait to Corteva Agriscience for total cash consideration of $4.0 million. On May 16, 2024, Arcadia sold the GoodWheat™ brand to Above Food for net consideration of $3.7 million. The assets sold consisted primarily of grain and finished goods inventories, formulations, and trademarks. On December 4, 2024, Arcadia, Roosevelt Resources LP, and Elliott Roosevelt, Jr. and David A. Roosevelt, as representatives of the limited partners of Roosevelt, entered into a Securities Exchange Agreement for the combination of the two companies in an all-stock transaction. Arcadia agreed to issue shares of its common stock to the limited partners and the sole member of the general partner of Roosevelt in exchange for all of the limited partnership and other equity interests of Roosevelt.

Arcadia Biosciences, Inc. (NASDAQ:RKDA) is a publicly traded company in the Energy & Transportation sector. Wiseek monitors RKDA SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Arcadia Biosciences Activates Resale of 11.9M Shares, Potential 546% Dilution
  • CEO Awarded $169K Bonus for 2025 Amidst Company's Financial Distress
  • Arcadia Biosciences Registers Resale of 11.9M Shares, Potential 546% Dilution
  • Arcadia Biosciences Closes $4M Private Placement with Extreme Dilution to Address Financial Distress
  • Distressed Arcadia Biosciences Closes $4M Private Placement, Bolstering Liquidity

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$4.86M
Net Income
-$2.34M
Diluted EPS
-$1.71
Op. Cash Flow
-$4.74M
Free Cash Flow
-$4.74M
Gross Profit
$1.76M
Operating Income
-$2.5M
Cash & Equivalents
$259K
Debt / Equity
0.00×
Net Margin
-48.1%
Shares Outstanding
1.37M sh
Source: 10-K · filed 2026-04-30 · accession 0001193125-26-197315

Dilution Risk

Low risk

Filing-implied dilution signals for RKDA, detected from its recent SEC filings · based on capital-structure filings through 2026-07-08.

2 recent capital raises1 shelf registration

Resale of 11.9 Million Shares Activated · Massive Potential Dilution

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with R →
$0.6388
52-week range · as of 2026-07-08 $0.6304 – $6.71
Market cap
$1.39M
Volume
13.4K (0.1× avg)
3-mo avg 189.7K
Live data · 2026-07-27 21:58 UTC · After hours

show_chartPrice Chart

Loading chart...

feed RKDA - Latest Insights

RKDA
Jul 08, 2026, 7:09 PM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $0.670
Real-time Price: $0.6388 info
Change: -$0.0312 (-5%) info
Market Cap: $1.394M info
RKDA
Jul 02, 2026, 4:21 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.733
Real-time Price: $0.6388 info
Change: -$0.0942 (-13%) info
Market Cap: $1.394M info
RKDA
Jun 26, 2026, 4:32 PM EDT
Filing Type: S-3
Importance Score:
9
Price at Filing: $0.6896
Real-time Price: $0.6388 info
Change: -$0.0508 (-7%) info
Market Cap: $1.394M info
RKDA
Jun 15, 2026, 11:31 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.01
Real-time Price: $0.6388 info
Change: -$0.3755 (-37%) info
Market Cap: $1.394M info
RKDA
Jun 12, 2026, 10:00 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.980
Real-time Price: $0.6388 info
Change: -$0.3412 (-35%) info
Market Cap: $1.394M info
RKDA
Jun 11, 2026, 8:00 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.17
Real-time Price: $0.6388 info
Change: -$0.5312 (-45%) info
Market Cap: $1.394M info
RKDA
May 14, 2026, 4:07 PM EDT
Filing Type: 10-Q
Importance Score:
10
Price at Filing: $1.05
Real-time Price: $0.6388 info
Change: -$0.4142 (-39%) info
Market Cap: $1.394M info
RKDA
May 14, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.07
Real-time Price: $0.6388 info
Change: -$0.4312 (-40%) info
Market Cap: $1.394M info
RKDA
Apr 03, 2026, 3:31 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.38
Real-time Price: $0.6388 info
Change: -$0.739 (-54%) info
Market Cap: $1.394M info
RKDA
Mar 26, 2026, 4:09 PM EDT
Filing Type: 10-K
Importance Score:
10
Price at Filing: $1.52
Real-time Price: $0.6388 info
Change: -$0.879 (-58%) info
Market Cap: $1.394M info
RKDA
Mar 26, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.52
Real-time Price: $0.6388 info
Change: -$0.879 (-58%) info
Market Cap: $1.394M info
RKDA
Mar 26, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.69
Real-time Price: $0.6388 info
Change: -$1.05 (-62%) info
Market Cap: $1.394M info
RKDA
Feb 10, 2026, 6:41 PM EST
Filing Type: 424B3
Importance Score:
9
Price at Filing: $1.80
Real-time Price: $0.6388 info
Change: -$1.16 (-65%) info
Market Cap: $1.394M info
RKDA
Feb 06, 2026, 4:03 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.80
Real-time Price: $0.6388 info
Change: -$1.16 (-65%) info
Market Cap: $1.394M info
RKDA
Jan 27, 2026, 8:45 PM EST
Filing Type: S-3
Importance Score:
9
Price at Filing: $2.23
Real-time Price: $0.6388 info
Change: -$1.59 (-71%) info
Market Cap: $1.394M info
RKDA
Jan 13, 2026, 8:07 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.55
Real-time Price: $0.6388 info
Change: -$1.91 (-75%) info
Market Cap: $1.394M info